Genmab | GEN - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Genmab

Genmab reported DKK829M in Debt for its fiscal quarter ending in March of 2023.


Debt Change
Almirall SA ALM:SM EUR 403.88M 12.53M
Amgen AMGN:US USD 61.6B 22.65B
AstraZeneca AZN:LN USD 31.5B 2.27B
Bayer BAYN:GR EUR 43.3B 1.65B
BioMarin Pharmaceutical BMRN:US USD 1.08B 1.48M
Demant A/s WDH:DC DKK 15.08B 1.66B
Galapagos GLPG:NA EUR 16M 5.9M
Genmab GEN:DC DKK 829M 232M
GlaxoSmithKline GSK:LN GBP 20.9B 82M
GN Store Nord GN:DC DKK 16.67B 418M
Hikma Pharmaceutical HIK:LN USD 1.28B 268M
Insmed INSM:US USD 1.16B 7.26M
Lonza Group LONN:SW CHF 2.23B 171M
Merck MRK:GR EUR 10.64B 246M
Novartis NOVN:VX USD 29.15B 1.24B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Roche Holding ROG:VX 25.35B 2.4B
UCB UCB:BB 2.9B 117M